Aurobindo Pharma received final approval from the US FDA to manufacture and market generic versions of Abilify tablets in various strengths. The approved product has an estimated US market size of $7.3 billion. Tata Motors' subsidiary Jaguar Land Rover will invest $2 billion in the first phase to set up a new manufacturing plant in Slovakia and expects to start production by 2018. Asian stocks advanced on Monday tracking a stronger lead from Wall Street on Friday, while markets in Japan were closed for a holiday.

1. SEBI Certified – Research Analyst www.choiceindia.com
Global View
India Update
Today’s Event/ Stock in News
Aurobindo Pharma has received the final approval from the US Food & Drug Administration (USFDA) to manufacture and market Aripiprazole
Tablets, 2mg, 5mg, 10mg, 15mg, 20mg and 30mg (ANDA 203908). The product is ready for launch. The approved ANDA is bioequivalent and
therapeutically equivalent to the reference listed drug product (RLD) Abilify Tablets 2mg, 5mg, 10mg, 15mg, 20mg and 30mg of Otsuka
Pharmaceutical Company (Otsuka). Aripiprazole Tablets are atypical antipsychotic indicated in the treatment symptoms of psychotic conditions
such as schizophrenia and bipolar disorder (manic depression). The approved product has an estimated market size of $7.3 Billion for the
twelve months ending August 2015 according to IMS. This is the 48th ANDA of the company to be approved out of Unit VII formulation facility
in Hyderabad, India for manufacturing Oral Non-Antibiotic products. Aurobindo now has a total of 215 ANDA approvals (187 Final approvals
including 10 from Aurolife Pharma LLC and 28 Tentative approvals) from USFDA.
Technical Outlook : On daily chart, stock has been trading in rising channel formation since last one year. Moreover, recently stock has taken
support of its lower band of channel formation at 730 levels on daily chart. Stock has formed doji candlestick followed by long bullish candle
stick, which give upside movement confirmation. Besides, stock has been trading above 60DEMA on daily chart, which indicates medium to
long term trend is up. The momentum indicator RSI has remained above 60 levels which point out for positive breath in the stock. So for
trading perspective, one could Buy in the range of 782-787 for the Target of 803 with the SL of 774
Tata Motors' subsidiary Jaguar Land Rover (JLR) will invest about $2 billion in the first phase to set up a manufacturing base in the Republic of
Slovakia. The company is planning to generate 400 jobs in the plant and 50,000 supplementary jobs in the allied sectors. The company is hoping
to start production by 2018. Tata Motors is India's largest automobile company. Through subsidiaries and associate companies, Tata Motors has
operations in the UK, South Korea, Thailand, South Africa and Indonesia. Among them is Jaguar Land Rover, the business comprising the two
iconic British brands.
Technical Outlook: The stock has given breakout of its falling trend line at 337.50 levels on daily chart with above average volumes which
indicators for strong upside movement. Moreover, stock has been trading above 60 DEMA on daily chart which shows that medium to long
term trend is up. The momentum indicator RSI has moved above 60 levels on daily chart which point out for positive breath in the stock. So for
trading perspective, one could Buy in the range of 353-356 for the Target of 364 with the SL of 349.
AUROPHARMA
TATAMOTORS
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Morning Tea
12th Oct 2015
Buy in the range of 353-356 for the Target of 364 with the SL of 349
Buy in the range of 782-787 for the Target of 803 with the SL of 774
Asian stocks outside Australia and Singapore advanced on Monday, tracking the slightly stronger lead from Wall Street. Meanwhile, markets in Japan
are closed for the Health and Sports Day holiday. China's share markets notched up early Monday, with the Shanghai Composite ticking up 0.2 percent,
following a report by the China Securities Journal that quoted a senior central banker saying that the country's stock market correction is "almost
over." Yi Gang, deputy governor of the People's Bank of China (PBOC) told an annual meeting of the International Monetary Fund (IMF) and World
Bank in Peru that the corrections in the mainland's equity market have had limited impact on the world's second-biggest economy as Beijing has taken
a series of measures to avoid systemic risks, Reuters reported. The Shanghai Composite index traded at 1.98% to 3247.61, Hang Seng index traded at
1.12 % to 22713.85, Japan's benchmark Nikkei 225 index traded at 1.61% to 18438.67, South Korea's Kospi index traded marginally up by 0.48 % to
2029.30 levels. The SGX Nifty suggests a gap up opening for our markets as it is trading at 8241, up by 45.50 points.
Major US averages finished higher on Friday, with the Nasdaq Composite leading gains by notching up 0.4 percent as investors digested dovish signals
from the US Federal Reserve minutes. The blue-chip Dow Jones Industrial Average and the S&P 500 ticked up 0.2 and 0.1 percent respectively. New
York Fed President William Dudley and Dennis Lockhart of the Atlanta Fed, speaking separately in New York, appeared doubtful they would have
enough information in hand to lift rates by an October 27-28 policy meeting, suggesting the Dec. 15-16 meeting is more likely. They also clearly left the
door open to waiting until 2016 if it looks like the US economy is threatened by a global slowdown. The central bank held off on a rate hike last month
in the face of a slowdown in China and elsewhere, financial market turbulence and falling commodity prices. All of those could keep US inflation, now
at 1.3 percent, below the Fed's 2 percent target. Since then, disappointing September jobs growth has caused investors to sharply discount an October
rate hike, and to give a December move about a 40 percent probability, based on futures markets. The Dow Jones industrial average rose 33.74 points,
or 0.20 percent, to 17084.49, the S&P 500 gained 1.46 points, or 0.07 percent, to 2014.89 and the Nasdaq Composite added 19.68 points, or 0.41
percent, to 4830.47.

2. SEBI Certified – Research Analyst www.choiceindia.com
Bulk Deal
Corporate Action / Result Calendar
SEBI Certified – Research Analyst www.choiceindia.com
Morning Tea
Corporate Action:
Result Calendar:
INFY, RIIL
12th Oct 2015
Security in Ban
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Sr.No Deal Date Security Code Security Name Client Name Deal Type Quantity Price
1 9/10/2015 517080 HIGHGROUND GREEN SAVVY PRODUCTIONS PVT LTD B 679271 78.89
2 9/10/2015 539334 SHREEPUSHK MUKUT BEHARI AGARWAL S 265000 69.98
3 9/10/2015 534731 BITL DASHRATH BABUBHAI RAVAL S 219643 42.14
4 9/10/2015 534731 BITL DASHRATH BABUBHAI RAVAL B 219643 42.12
5 9/10/2015 534731 BITL CHUNILAL NATHALAL MUDETHIYA S 216080 42.13
6 9/10/2015 534731 BITL CHUNILAL NATHALAL MUDETHIYA B 216080 42.13
7 9/10/2015 534731 BITL SEJAL SAURABHBHAI SHAH S 201355 42.18
8 9/10/2015 534731 BITL SEJAL SAURABHBHAI SHAH B 201355 42.18
9 9/10/2015 534731 BITL KALIBEN KALAJI THAKOR S 201344 42.18
10 9/10/2015 534731 BITL KALIBEN KALAJI THAKOR B 201344 42.16

3. SEBI Certified – Research Analyst www.choiceindia.com
Contact Us
www.choiceindia.com
www.choiceindia.comcustomercare@choiceindia.com
Disclaimer
This is solely for information of clients of Choice Broking and does not construe to be an investment advice. It is also not intended as an offer or solicitation for the purchase and sale of any financial
instruments. Any action taken by you on the basis of the information contained herein is your responsibility alone and Choice Broking its subsidiaries or its employees or associates will not be liable in
any manner for the consequences of such action taken by you. We have exercised due diligence in checking the correctness and authenticity of the information contained in this recommendation, but
Choice Broking or any of its subsidiaries or associates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the
information contained in this recommendation or any action taken on basis of this information. Technical analysis studies market psychology, price patterns and volume levels. It is used to forecast
future price and market movements. Technical analysis is complementary to fundamental analysis and news sources. The recommendations issued herewith might be contrary to recommendations
issued by Choice Broking in the company research undertaken as the recommendations stated in this report is derived purely from technical analysis. Choice Broking has based this document on
information obtained from sources it believes to be reliable but which it has not independently verified; Choice Broking makes no guarantee, representation or warranty and accepts no responsibility
or liability as to its accuracy or completeness. The opinions contained within the report are based upon publicly available information at the time of publication and are subject to change without
notice. The information and any disclosures provided herein are in summary form and have been prepared for informational purposes. The recommendations and suggested price levels are intended
purely for trading purposes. The recommendations are valid for the day of the report however trading trends and volumes might vary substantially on an intraday basis and the recommendations may
be subject to change. The information and any disclosures provided herein may be considered confidential. Any use, distribution, modification, copying, forwarding or disclosure by any person is
strictly prohibited. The information and any disclosures provided herein do not constitute a solicitation or offer to purchase or sell any security or other financial product or instrument. The current
performance may be unaudited. Past performance does not guarantee future returns. There can be no assurance that investments will achieve any targeted rates of return, and there is no guarantee
against the loss of your entire investment.
POTENTIAL CONFLICT OF INTEREST DISCLOSURE (as on date of report) Disclosure of interest statement – • Analyst interest of the stock /Instrument(s): - No. • Firm interest of the stock /
Instrument (s): - No.
SEBI Certified – Research Analyst www.choiceindia.com
Research Team
Mr. Sumeet Bagadia Associate Director
Kunal Parmar Research Associate
Ritesh Patel Research Associate
Amit Pathania Research Associate
Vikas Chaudhari Research Associate
Rajnath Yadav Research Associate
Satish Kumar Research Associate
Morning Tea
12th Oct 2015
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Kunal Parmar
Digitally signed by Kunal Parmar
DN: cn=Kunal Parmar, o=Choice Equity Broking Pvt
Ltd., ou=Research Dept.,
email=kunal.parmar@choiceindia.com, c=IN
Date: 2015.10.12 08:29:03 +05'30'